US 12358896
LRRK2 inhibitors and methods of making and using thereof
granted A61PA61P25/16A61P25/28
Quick answer
US patent 12358896 (LRRK2 inhibitors and methods of making and using thereof) held by DENALI THERAPEUTICS INC. expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DENALI THERAPEUTICS INC.
- Grant date
- Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P25/16, A61P25/28, A61P29/00, A61P35/00